Muscle Adverse Events Associated with Inclisiran: Data Mining of FAERS database and Mendelian Randomization Analysis
{{output}}
Inclisiran, the first small interfering RNA (siRNA) lipid lowering drug, has reported muscle adverse events (MAEs), but long-term safety is unclear. This study is based on data obtained from the Food and Drug Administration Adverse Event Reporting System (FAER... ...
